Patients from 22+ countriesPlan your visit →
lutetium-therapy
Caregiver Treatment Decisions · 2 Aug 2026

Lu-177 PSMA Caregiver Guide for mCRPC Families

If your husband, father, or partner is starting lutetium Lu-177 PSMA therapy for metastatic castration-resistant prostate cancer, this guide explains the radiation safety rules you must follow at home, which side effects to watch for between cycles, and how to protect your own health across a treatment course that may run six months or longer.

Editorial oversight by Arpan Talwar·Founder, Art of Healing CancerUpdated 2 Aug 2026
Lu-177 PSMA Caregiver Guide for mCRPC Families

This guide helps caregivers of men with metastatic castration-resistant prostate cancer (mCRPC) - advanced prostate cancer that has stopped responding to hormone therapy. If your husband, father, or partner has been offered lutetium Lu-177 vipivotide tetraxetan (brand name: Pluvicto), a targeted radioligand therapy, this guide covers the practical and emotional side of supporting him through up to six treatment cycles.

The short answer to "what does a caregiver actually do?" is this: you help enforce radiation safety rules at home for up to seven days after each cycle, watch for side effects between doses, manage appointments and travel for a multi-cycle course, and protect your own health through a process that often takes six months or longer.

What Happens During a Lu-177 PSMA Treatment Cycle?

Lutetium Lu-177 vipivotide tetraxetan targets PSMA - prostate-specific membrane antigen, a protein found on the surface of most prostate cancer cells. The radioactive molecule binds to cancer cells and delivers radiation to damage their DNA. A doctor gives treatment as a slow infusion at a licensed nuclear-medicine center, usually one dose every six weeks for up to six cycles. Most patients go home the same day with written safety instructions.

Your loved one's care team will not typically allow companions into the active treatment room during the infusion - the room is a controlled radiation area. You may be asked to wait in a nearby area. Plan for a full day out, bring something to read, and confirm the center's visitor policy ahead of each visit.

Radiation Safety Rules You Must Follow at Home

After each infusion, a small amount of radioactivity leaves the body through urine and other body fluids over several days. The FDA prescribing information for Pluvicto sets out specific precautions that both the patient and household members must follow after every cycle, not just the first.

The core rules are:

  • Limit time within 3 feet of other adults for 2 days after each dose; with children or pregnant women, maintain that distance for 7 days.
  • Sleep in a separate room from other adults for 3 days; from children for 7 days; from pregnant women for 15 days.
  • Avoid sexual activity for 7 days after each dose.
  • Your loved one should shower daily for at least the first 7 days after treatment.
  • He should sit when using the toilet and flush at least twice after each use.
  • Wash any clothing, bed linen, or towels stained with urine or sweat separately from the rest of the household laundry.
  • Wear disposable gloves if you handle soiled items, and wash your hands thoroughly afterwards.

These precautions exist because the radioactivity in body fluids is real, even at the low levels present in a home setting. Lutetium-177 has a physical half-life of approximately 6.7 days, meaning the radioactivity in the body roughly halves each week. By around day 14 after a cycle, most of it has decayed. The nuclear-medicine team will give you a written safety sheet after each infusion - keep it somewhere easy to find, and re-read it before each new cycle.

For a day-by-day breakdown of what these rules mean in practice, the guide on radiation safety after Lu-177 PSMA therapy covers each precaution in plain language, including what to do if your household has only one bathroom.

Side Effects to Watch For - and How You Can Help

In the trial that led to FDA approval of this therapy, about 43% of patients reported fatigue, though most cases were mild to moderate. Dry mouth, nausea, and changes in blood counts were also common side effects. Knowing what to watch for lets you act quickly when something needs attention.

Fatigue

Fatigue after lutetium therapy tends to peak in the first few days after each infusion and then ease before the next cycle. Some patients find it builds across later cycles. You can help by planning quieter days in the week following each dose, taking over physically demanding household tasks during that week, and letting him rest when his body needs it. The guide on managing fatigue during and after Lu-177 PSMA therapy explains why it happens and what tends to help most.

Dry Mouth and Nausea

Salivary glands carry PSMA receptors, which is why dry mouth is an expected side effect of this therapy. It can make eating or swallowing less comfortable. Soft, moist foods tend to help. For nausea, avoiding strong cooking smells in the days immediately after treatment is a practical step. Anti-nausea medications are often prescribed by the care team - fill these before treatment day so they are already at home when they are needed.

Blood Count Changes

Lutetium therapy can reduce red blood cell, white blood cell, and platelet counts. In the trial that led to approval, about 13% of patients had severe anemia and similar numbers had low white blood cell counts. The care team will schedule blood tests between cycles to track these values. As a caregiver, watch for signs of infection (fever above 38 degrees Celsius, chills), unusual bruising, cuts that won't stop bleeding, or extreme paleness. Call the oncology team right away if you see any of these. The article on bone marrow suppression and low blood counts during Lu-177 PSMA therapy explains what blood test values mean and when to call for help.

Managing the Practical Side of a Multi-Cycle Course

The logistics of six cycles can pile up, especially if treatment involves travel. A few habits tend to keep things manageable:

  • Keep all scan images, blood test results, referral letters, and cycle dates in a single folder - paper or digital - and share access with anyone who may accompany your loved one to appointments.
  • Maintain an up-to-date medication list that includes each drug's name, dose, and purpose. The list often changes during treatment.
  • Write down any new symptoms that appear between cycles and bring that list to every appointment. The care team can only act on what they are told about.
  • Book transport and accommodation well in advance, particularly if treatment requires travel to another city or country.
  • Ask the nuclear-medicine team at least one week before each cycle whether pre-treatment instructions apply - such as holding certain medications, fasting, or increasing fluid intake beforehand.

If your loved one is considering traveling internationally for treatment - as many patients from the GCC, Africa, and South Asia now do, because Lu-177 PSMA therapy may be unavailable or very costly at home - get answers about eligibility and logistics before booking flights. You can speak with the Art of Healing Cancer nuclear-medicine team to clarify whether your loved one qualifies, what documents the center needs, and what the full cycle schedule will look like in practice.

Helping Your Loved One Through Emotional Shifts

A man receiving this therapy carries a serious cancer diagnosis while managing side effects that change weekly. Hope and anxiety can alternate within a single day. On high-fatigue days he may become withdrawn or short-tempered. This is common. It doesn't mean anything is wrong with your relationship or how treatment is working.

A few approaches that tend to help:

  • Ask open questions. "How are you feeling today?" invites more than "You look fine."
  • Do not pressure optimism. Letting someone name a fear is often more useful than reassuring them it cannot happen.
  • Keep routines where possible. Predictability tends to reduce the background anxiety that builds during a long treatment course.
  • Ask the care center whether a patient navigator, social worker, or oncology psychologist is available. Many cancer centers offer this at no additional cost to the patient.

The Prostate Cancer Foundation caregiver resource page includes a free, moderated online support group for partners and family members of men with prostate cancer. Hearing from others who are managing the same role can reduce the isolation that often builds quietly across a long treatment course.

Taking Care of Yourself Through This

Caregiver burnout is real. It's not a character flaw. Caregivers of men with prostate cancer often experience anxiety. Support helps both of you. You cannot give consistent care if your own resources are depleted.

A few things worth protecting deliberately:

  • Sleep. Use nights when you sleep apart to rest fully instead of checking on him. These rules are about reducing radiation, not because he needs watching all night.
  • Regular meals. It's easy to skip eating when everything feels overwhelming, but it catches up with you fast.
  • At least one social activity or connection outside caregiving. This helps you stay grounded over months.
  • Your own medical check-ups. It's easy to skip these when focused on someone else's care. Keep them up.

If anxiety or sleep problems are affecting your daily life, talk to your doctor about support options.

The Prostate Cancer Foundation has a guide on managing stress and anxiety that lists when therapy, couples counseling, or support groups can help most.

Questions Worth Bringing to Each Appointment

  • What are the specific radiation safety rules for this cycle, and do any of them change across cycles?
  • Which blood test values should prompt an urgent call between cycles?
  • Are there medications or supplements that need to be stopped or adjusted before this dose?
  • What signs might lead you to delay the next cycle?
  • Is there a 24-hour contact number for urgent concerns between cycles?

When to Contact the Care Team Right Away

Between cycles, contact the oncology or nuclear-medicine team promptly if your loved one develops any of the following:

  • Fever above 38 degrees Celsius, or chills that suggest infection
  • Unusual or unexpected bruising, or a cut or graze that does not stop bleeding
  • Fatigue severe enough to prevent him from getting out of bed
  • Nausea or vomiting that prevents eating or keeping fluids down
  • Sudden new bone pain, or worsening pain that current medications are not controlling
  • Very low urine output, or pain on urination

Also speak with the care team if you have questions about the radiation safety rules given your specific household - for example, if a young child or pregnant person lives with you, the precautions may need to be adjusted.

If you are still working out whether Lu-177 PSMA therapy is the right next step, or have questions about access, treatment sequencing, or what to do if eligibility is not confirmed, you are welcome to send the PSMA-PET scan and treatment history to the Lutetium Therapy team for a review. If Lu-177 PSMA is not a fit, the team can advise on what alternative options may be available.

This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.

Frequently asked questions

How long do the radiation safety precautions last after each Lu-177 PSMA dose?

The precautions are most important in the first 7 days after each infusion. According to the FDA prescribing information for Pluvicto, close contact within 3 feet should be limited with other adults for 2 days, and with children or pregnant women for 7 days. Separate sleeping arrangements apply for 3 days from other adults, 7 days from children, and 15 days from pregnant women. The nuclear-medicine team will provide a written safety sheet after every cycle - the rules apply after each dose, not just the first.

Can I hug or touch my loved one during his Lu-177 PSMA treatment course?

A brief hug is different from sustained close contact, but the FDA prescribing information recommends limiting time within 3 feet of others for at least 2 days after each cycle, and 7 days for children or pregnant women. If you are unsure what is safe given your household situation, ask the nuclear-medicine team for personalised guidance before each infusion. They are used to answering these questions and can tailor advice to your home.

What side effects should I watch for most closely as a caregiver?

Based on VISION trial data, the most common side effects of lutetium Lu-177 vipivotide tetraxetan are fatigue, dry mouth, nausea, and changes in blood counts. Severe anaemia and low white blood cell counts each occurred in roughly 13% of patients in the trial. Watch for signs of infection (fever above 38 degrees Celsius), unusual bruising, cuts that do not stop bleeding, and extreme tiredness. Contact the care team promptly if any of these appear between cycles.

What should I do if I feel overwhelmed as a caregiver?

Caregiver stress in advanced cancer is a well-recognised clinical concern. Research indexed through the US National Institutes of Health suggests it commonly involves anxiety and that targeted psychosocial support improves outcomes for both caregiver and patient. Your loved one's cancer centre may have a social worker, oncology psychologist, or patient navigator available at no additional cost. The Prostate Cancer Foundation also runs a free moderated online support group for caregivers of men with prostate cancer. Speak with your own doctor if stress or sleep disruption is affecting your daily functioning.

Do I need to travel with my loved one to every treatment cycle?

For the first cycle it is strongly advisable to travel together so you can learn the safety protocols firsthand and assess what help is actually needed on treatment days. For later cycles, many international patients travel with less support once routines are established. Make each decision based on your loved one's energy levels, the length of the journey, and how the side effects have been running. Some centres have patient liaison staff who can assist with logistics if a companion cannot travel every time.

What documents should I keep track of across the treatment course?

Keep a single folder - paper or digital - containing all PSMA-PET scan images and reports, the most recent blood test results, referral letters from the oncologist, a current medication list with doses and purposes, and discharge summaries from each completed cycle. Also keep the radiation safety sheet issued after each infusion. If treatment involves travel, carry printed copies of the key documents as a backup in case digital access fails.

Have a specific question about your situation?

A free conversation with a patient navigator can help you understand whether Lutetium therapy fits your case, what questions to ask your oncologist, and which centers might be right for you.

Navigators don't diagnose or prescribe. They help you have better conversations with the doctors who do.

Caregiver Guide to Lu-177 PSMA Therapy for mCRPC | lutetium-therapy